Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique,...

Area of Science:

• Ophthalmology
• Glaucoma Management
• Laser Therapy

Background:

• Glaucoma is a leading cause of irreversible blindness worldwide.
• MicroPulse Transscleral Laser Treatment (TLT) is an emerging therapeutic option for glaucoma.
• Standardized guidelines for MicroPulse TLT are needed to ensure optimal clinical application.

Purpose of the Study:

• To establish expert consensus and evidence-based guidelines for MicroPulse Transscleral Laser Treatment (TLT).
• To cover treatment techniques, postoperative care, expected outcomes, and retreatment strategies for MicroPulse TLT.

Main Methods:

• A systematic literature search of PubMed identified 61 relevant studies on MicroPulse TLT.
• A three-round Delphi method involving 10 international glaucoma experts was employed.
• Consensus was achieved through aggregated responses and a live meeting with 90% attendance.

Main Results:

• High response rates were achieved in all rounds of the Delphi method (70%, 70%, 80%).
• Consensus was reached on key aspects of MicroPulse TLT, including technique, care, and outcomes.
• The findings provide comprehensive guidance for the application of MicroPulse TLT.

Conclusions:

• MicroPulse TLT is a safe and effective treatment for diverse glaucoma types and severities when used with appropriate parameters, technique, and patient selection.
• MicroPulse TLT represents a valuable addition to the available glaucoma treatment armamentarium.